Overview


According to FutureWise analysis the market for Multimodal Imaging in 2023 is US$ 4.2 billion, and is expected to reach US$ 6.65 billion by 2031 at a CAGR of 5.92%.

Advancements in diagnostic imaging technology, broadened range of applications in multimodal imaging systems, increased research funding, favourable reimbursement policies, increased research and development in radiotracers and rise in the insurance coverage are the key driving factors of the market. Multimodal imaging is mainly used for drug discovery and in non-invasive and invasive surgical procedures which shall augment the multimodal imaging market growth. The optical fluorescence imaging has garnered a huge demand as it is very efficient in providing real-time images. This imaging method is used extensively for studying molecular events which is why it is often deployed in surgeries that require image guidance. All these factors shall bolster the growth of the market.

  • Koninklijke Philips N.V.
  • Canon Inc.
  • United Imaging Healthcare Co. Ltd.
  • Siemens
  • Mediso Medical Imaging Systems Kft
  • Neusoft Medical Systems Co. Ltd.
  • Infraredx Inc.
  • Spectrum Dynamics Medical
  • Topcon Corporation
  • GE Healthcare
  • Heidelberg Engineering
  • Carl Zeiss AG
  • Optovue Inc.
  • Nidek Co., Ltd.
  • Optos Plc (UK) (a part of Nikon Corporation)
  • Kowa Company Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  • PET-CT
  • SPECT-CT
  • PET-MR
  • OCT
  • Trimodal       

By Application

  • Cardiology
  • Brain and Neurology
  • Ophthalmology
  • Oncology
  • Others    

By End User 

  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Users    

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is classified into technology, application, end user and region. The technology segment is fragmented into PET-CT, SPECT-CT, PET-MR, OCT and Trimodal. The PET-CT systems held the largest multimodal imaging market share owing to the rising insistence for accurate and early diagnosis of cancer, increased clinical evidence for detecting Alzheimer’s disease as early as possible. The application segment is divided into cardiology, brain and neurology, ophthalmology, oncology and other applications. The oncology segment is predicted to dominate the market owing to the rising incidence of cancer across the world, extensive usage of multimodal system for diagnosing tumors. The end user segment is bifurcated into diagnostic imaging centres, hospitals and other end users. The hospital segment subjugated the market owing to increased installations of advanced imaging systems such as SPECT-CT and PET-CT, increased demand for diagnostic processes that are non-invasive in nature.

The North America region is expected to lead the market owing to the integration of advanced multimodal imaging systems in hospital settings, improves reimbursement scenario, increased financial assistance pertaining to the novel imaging systems. However, the Asia Pacific region is predicted to grow at a substantial rate during the forecast period and this can be credited to improvements in the healthcare infrastructure, increasing patient population and improving insurance coverage policies.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global multimodal imaging market by technology, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Multimodal Imaging Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Multimodal Imaging Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Multimodal Imaging Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Multimodal Imaging Market, By Technology Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. PET-CT
        2. SPECT-CT
        3. PET-MR
        4. OCT
        5 .Trimodal

  • 8.   Multimodal Imaging Market, By Application Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Cardiology
        2. Brain and Neurology
        3. Ophthalmology
        4. Oncology
        5. Others

  • 9.   Multimodal Imaging Market, By End User Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Hospitals
        2. Diagnostic Imaging Centers
        3. Other End Users

  • 10.   North America Multimodal Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Multimodal Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Multimodal Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Multimodal Imaging Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •          1. Koninklijke Philips N.V.
                   1.1. Company Overview (HQ, Business Segments, Employee Strength)
                   1.2. Product Portfolio
                   1.3. SWOT Analysis
                   1.4. Financial Overview
                   1.5. Strategic Overview
                2. Canon Inc.
                    2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    2.2. Product Portfolio
                    2.3. SWOT Analysis
                    2.4. Financial Overview
                    2.5. Strategic Overview
              3. United Imaging Healthcare Co. Ltd.
                    3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    3.2. Product Portfolio
                    3.3. SWOT Analysis
                    3.4. Financial Overview
                    3.5. Strategic Overview
              4. Siemens
                   4.1. Company Overview (HQ, Business Segments, Employee Strength)
                   4.2. Product Portfolio
                   4.3. SWOT Analysis
                   4.4. Financial Overview
                   4.5. Strategic Overview
               5. Mediso Medical Imaging Systems Kft
                    5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    5.2. Product Portfolio
                    5.3. SWOT Analysis
                    5.4. Financial Overview
                    5.5. Strategic Overview
               6. Neusoft Medical Systems Co. Ltd.
                    6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    6.2. Product Portfolio
                    6.3. SWOT Analysis
                    6.4. Financial Overview
                    6.5. Strategic Overview
                7. Infraredx Inc.
                   7.1. Company Overview (HQ, Business Segments, Employee Strength)
                   7.2. Product Portfolio
                   7.3. SWOT Analysis
                   7.4. Financial Overview
                   7.5. Strategic Overview
              8. Spectrum Dynamics Medical
                    8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    8.2. Product Portfolio
                    8.3. SWOT Analysis
                    8.4. Financial Overview
                    8.5. Strategic Overview    
             9. Topcon Corporation
                    9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    9.2. Product Portfolio
                    9.3. SWOT Analysis
                    9.4. Financial Overview
                    9.5. Strategic Overview
            10. GE Healthcare
                    10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    10.2. Product Portfolio
                    10.3. SWOT Analysis
                    10.4. Financial Overview
                    10.5. Strategic Overview
            11. Heidelberg Engineering
                    11.1. Company Overview (HQ, Business Segments, Employee Strength)
                    11.2. Product Portfolio
                    11.3. SWOT Analysis
                    11.4. Financial Overview
                    11.5. Strategic Overview
             12. Carl Zeiss AG
                   12.1. Company Overview (HQ, Business Segments, Employee Strength)
                   12.2. Product Portfolio
                   12.3. SWOT Analysis
                   12.4. Financial Overview
                   12.5. Strategic Overview
              13. Optovue Inc.
                  13.1. Company Overview (HQ, Business Segments, Employee Strength)
                  13.2. Product Portfolio
                  13.3. SWOT Analysis
                  13.4. Financial Overview
                  13.5. Strategic Overview
             14. Nidek Co., Ltd.
                  14.1. Company Overview (HQ, Business Segments, Employee Strength)
                  14.2. Product Portfolio
                  14.3. SWOT Analysis
                  14.4. Financial Overview
                  14.5. Strategic Overview
            15. Optos Plc (UK) (a part of Nikon Corporation)
                  15.1. Company Overview (HQ, Business Segments, Employee Strength)
                  15.2. Product Portfolio
                  15.3. SWOT Analysis
                  15.4. Financial Overview
                  15.5. Strategic Overview
          16. Kowa Company Ltd.
                  16.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.2. Product Portfolio
                  16.3. SWOT Analysis
                  16.4. Financial Overview
                  16.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11